Loading organizations...
§ Private Profile · Lisbon, Lisboa, Portugal
UpHill is a technology company.
UpHill provides an intelligent care platform optimizing clinical workflows and delivery. It integrates conversational AI, automation, and orchestration to manage data and patient interactions efficiently. The platform synthesizes health data, engages patients, and offers actionable insights, boosting clinical capacity and focus by reducing administrative burdens. A Class IIa Medical Device, this technology streamlines critical processes.
Founded in 2015 by Eduardo Freire Rodrigues, Luís Patrão, Luis Boss, and Duarte, UpHill arose from the insight that healthcare professionals are overburdened by automatable tasks. Eduardo Freire Rodrigues observed administrative overhead hindering patient care, prompting the founders to empower clinicians. Their vision was to build a system that alleviates this burden, allowing medical teams to concentrate on their primary mission.
UpHill serves hospitals and health systems, offering solutions for acute, cancer, chronic, and surgical care. The company envisions clinical teams prioritizing exceptional patient care by transforming coordination. UpHill aims to improve patient outcomes, optimize resource utilization, and foster a scalable, sustainable healthcare system, ultimately enhancing care quality across various medical specialties.
UpHill has raised $12.1M across 2 funding rounds.
UpHill has raised $12.1M in total across 2 funding rounds.
UpHill has raised $12.1M across 2 funding rounds. Most recently, it raised $8.0M Series A in March 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2024 | $8M Series A | Brighteye Ventures, Joao Caro DE Sousa, Mustard Seed Maze, Lucas Paul | Speedinvest, Nicolas Steegmann, Thibaud Elziere, Caixa Capital Risc, LUZ Saude, SCR | Announced |
| Sep 13, 2021 | $4.1M Seed | Alex Latsis, Mustard Seed Maze | Bynd, Caixa Capital Risc, LUZ Saude | Announced |
UpHill has raised $12.1M in total across 2 funding rounds.
UpHill's investors include Brighteye Ventures, Joao Caro de Sousa, Mustard Seed Maze, Lucas Paul, Speedinvest, Nicolas Steegmann, Thibaud Elziere, Caixa Capital, Luz Saude, SCR, Alex Latsis, Bynd.
UpHill is a Lisbon-based health tech company developing a B2B SaaS platform that streamlines healthcare processes to enhance patient care.[3] It serves healthcare organizations by automating workflows, supporting clinical decision-making, and coordinating care journeys, addressing inefficiencies in care orchestration beyond basic telemonitoring.[2][3] The platform has achieved European Class IIa medical device certification through rigorous independent audits, ensuring high standards of safety and quality—distinguishing it from simpler Class I self-declared options.[2] UpHill has raised $8.3 million across two funding rounds from six investors, signaling strong growth momentum in the competitive health tech sector.[3]
UpHill emerged in Lisbon as a health tech startup focused on B2B SaaS for healthcare process optimization, though specific founding year and founder details are not detailed in available records.[3] A pivotal moment came with its achievement of European Class IIa medical device certification, highlighting its early commitment to complex care orchestration features like workflow automation and team coordination, which underwent in-depth audits by EU-designated bodies.[2] This certification underscores rapid traction in regulatory compliance, positioning UpHill as a reliable partner for healthcare transformation amid rising demands for advanced, compliant digital tools.[1][2]
(Note: Search results do not specify exact founders or initial idea origins; it is distinct from older entities like Uphill Technologies Limited, a UK ICT consultancy founded around 2010.[4])
UpHill rides the wave of digital health transformation, where AI-driven care orchestration meets post-pandemic demands for efficient, coordinated patient management.[2][3] Timing is ideal amid Europe's stringent MDR regulations, as Class IIa certification positions it favorably against less rigorous competitors, capitalizing on market forces like aging populations and healthcare staffing shortages.[2] By influencing the ecosystem through scalable SaaS, UpHill enables providers to automate beyond data silos, fostering broader adoption of compliant tech in a sector projected for rapid growth.[3]
UpHill's certified platform sets it up for accelerated enterprise adoption, with potential expansion into AI-enhanced features for predictive care coordination. Trends like regulatory tightening and value-based care will amplify its edge, evolving its influence from niche innovator to ecosystem leader in European health tech. As funding fuels global scaling, expect partnerships with major providers to redefine streamlined care.